But that was before the U.S. Food and Drug Administration, Health Canada and other public health agencies approved the company's vaccine for emergency use. "We and our partner Pfizer have crossed the one billion mark for COVID-19 vaccine doses shipped worldwide," CEO Ugur Sahin said in a release. The company says it will use its profits from its COVID-19 vaccine to develop and produce vaccines against other viruses. The funds the company is making from its COVID vaccine will be used to develop those vaccines and others. BioNTech expects results from at least four of them to be released by the end of the year.

Source: CBC News August 09, 2021 14:31 UTC